Get started
444

INNOPHARMAX INC

No trades
See on Supercharts
Overview
Financials Discussions Technicals Seasonals

4172 chart


Full chart

Key stats


Market capitalization
‪1.82 B‬ TWD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.90 TWD
Net income (FY)
‪−70.83 M‬ TWD
Revenue (FY)
‪46.07 M‬ TWD
Shares float
‪80.23 M‬
Beta (1Y)
0.33

About INNOPHARMAX INC


Sector
Health Technology
CEO
Wei Hua Hao
Headquarters
Taipei
Website
innopharmax.com.tw
Founded
2005
ISIN
TW0004172002
FIGI
BBG003CC2VR3
InnoPharmax, Inc. engages in the development and commercialization of pharmaceutical products for the treatment of oncology and specialty. Its product categories include anti-infection agents, contrast agents, oncology agents, immunological agents, and drugs for rare diseases. The company was founded on October 27, 2005 and is headquartered in Taipei, Taiwan.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 4172 is 19.10 TWD — it has decreased by −1.04% in the past 24 hours. Watch INNOPHARMAX INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange INNOPHARMAX INC stocks are traded under the ticker 4172.
4172 stock hasn't changed in a week, the month change is a −0.52% fall, over the last year INNOPHARMAX INC has showed a −16.39% decrease.
4172 reached its all-time high on May 9, 2014 with the price of 85.15 TWD, and its all-time low was 6.45 TWD and was reached on Nov 27, 2018. View more price dynamics on 4172 chart.
See other stocks reaching their highest and lowest prices.
4172 stock is 2.41% volatile and has beta coefficient of 0.33. Track INNOPHARMAX INC stock price on the chart and check out the list of the most volatile stocks — is INNOPHARMAX INC there?
Today INNOPHARMAX INC has the market capitalization of ‪1.82 B‬, it has increased by 1.05% over the last week.
Yes, you can track INNOPHARMAX INC financials in yearly and quarterly reports right on TradingView.
4172 net income for the last half-year is ‪−42.54 M‬ TWD, while the previous report showed ‪−40.98 M‬ TWD of net income which accounts for −3.82% change. Track more INNOPHARMAX INC financial stats to get the full picture.
No, 4172 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INNOPHARMAX INC EBITDA is ‪−73.62 M‬ TWD, and current EBITDA margin is −125.01%. See more stats in INNOPHARMAX INC financial statements.
Like other stocks, 4172 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INNOPHARMAX INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So INNOPHARMAX INC technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating INNOPHARMAX INC stock shows the neutral signal. See more of INNOPHARMAX INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.